Ofatumumab in Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease: A Comparison With Rituximab. Fan Y, Zhou L, ZhangBao J, Tan H, Wang Z, Quan C Ann Clin Transl Neurol. 2026 Apr 26. PMID: 42036830. Abstract CommentRecommendBookmarkWatch
